Directori de persones
Farida Dakterzada Sedaghat

Farida Dakterzada Sedaghat

Grau: Doctor/a

973702413
fdakterzada(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/G-4155-2016

Grups

Publicacions

  • Vazquez-Justes, D; Aguirregoicoa, I; Fernandez, L; Carnes-Vendrell, A; Dakterzada, F; Sanjuan, L; Mena, A; Piñol-Ripoll G

    Clinical impact of microbleeds in patients with Alzheimer's disease.

    BMC Geriatrics 22 774-774. .

    [doi:10.1186/s12877-022-03456-y]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Grill E; Buil R; de Batlle J; Piñol-Ripoll G

    Benzodiazepine and Z-drug use and the risk of developing dementia.

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 25 261-268. .

    [doi:10.1093/ijnp/pyab073]

  • Targa ADS; Benítez ID; Dakterzada F; Carnes A; Pujol M; Jorge C; Minguez O; Dalmases M; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Sleep profile predicts the cognitive decline of mild-moderate Alzheimer's disease patients.

    Sleep 44 -. .

    [doi:10.1093/sleep/zsab117]

  • Targa ADS; Benítez ID; Dakterzada F; Fontenele-Araujo J; Minguez O; Zetterberg H; Blennow K; Barbé F; Piñol-Ripoll G

    The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer's disease patients.

    Alzheimers Research & Therapy 13 161-161. .

    [doi:10.1186/s13195-021-00903-7]

  • Dakterzada F; David Benítez I; Targa A; Lladó A; Torres G; Romero L; de Gonzalo-Calvo D; Moncusí-Moix A; Tort-Merino A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's Disease.

    FRONTIERS IN AGING NEUROSCIENCE 13 705989-705989. .

    [doi:10.3389/fnagi.2021.705989]

  • Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G

    Level of understanding of Alzheimer disease among caregivers and the general population.

    NEUROLOGIA 36 426-432. .

    [doi:10.1016/j.nrleng.2018.03.004]

  • Dakterzada F; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Piñol-Ripoll G

    Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest.

    FRONTIERS IN AGING NEUROSCIENCE 13 604119-604119. .

    [doi:10.3389/fnagi.2021.604119]

  • Targa A; Dakterzada F; Benítez I; López R; Pujol M; Dalmases M; Arias A; Sánchez-de-la-Torre M; Zettenberg H; Blennow K; Pamplona R; Jové M; Barbé F; Piñol-Ripoll G

    Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients.

    Sleep 44 -. .

    [doi:10.1093/sleep/zsaa147]

  • Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.

    Alzheimers Research & Therapy 12 163-163. .

    [doi:10.1186/s13195-020-00735-x]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Gill E; Buil R; de Batlle J; Piñol-Ripoll G

    Proton pump inhibitors and the risk of Alzheimer's disease and non-Alzheimer's dementias.

    SCIENTIFIC REPORTS 10 21046-21046. .

    [doi:10.1038/s41598-020-78199-0]

  • Jorge C; Targa A; Benítez ID; Dakterzada F; Torres G; Minguez O; Carnes A; Pujol M; Gibert A; López R; Gaeta AM; Dalmases M; Farré R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease.

    EUROPEAN RESPIRATORY JOURNAL 56 -. .

    [doi:10.1183/13993003.00523-2020]

  • Targa, A; Dakterzada, F; Benitez, ID; de Gonzalo-Calvo, D; Moncusi-Moix, A; Lopez, R; Pujol, M; Arias, A; de Batlle, J; Sanchez-de-la-Torre, M; Barbe, F; Piñol-Ripoll G

    Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer's Disease.

    MOLECULAR NEUROBIOLOGY 57 4363-4372. .

    [doi:10.1007/s12035-020-02031-z]

Projectes

  • Insight into the role of lipids in frontotemporal dementia: uncovering pathophysiological alterations and biomarker discovery opportunities.
  • Development of dynamic models for the personalized prevention and treatment of age-related diseases
  • Importancia del sueño y los ritmos circadianos en la biología y evolución clínica de los sujetos en el continuum de la Enfermedad de Alzheimer.
  • Ajuts per a la contractació de personal investigador novell (FI-2019)
  • Biomarcadores lipidómicos de la progresión de la enfermedad de Alzheimer en pacientes con deterioro cognitivo leve
  • Programes de recerca: estudi de biomarcadors i desenvolupament de noves estratègies terapèutiques en una cohort multicèntrica de Demència Frontotemporal